16-1229314-C-G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate

The NM_024164.6(TPSB2):​c.376G>C​(p.Glu126Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 3)
Exomes 𝑓: 0.00074 ( 23 hom. )
Failed GnomAD Quality Control

Consequence

TPSB2
NM_024164.6 missense

Scores

1
12

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.00
Variant links:
Genes affected
TPSB2 (HGNC:14120): (tryptase beta 2) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, beta II and beta III. Beta tryptases appear to be the main isoenzymes expressed in mast cells, whereas in basophils, alpha-tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018770158).
BP6
Variant 16-1229314-C-G is Benign according to our data. Variant chr16-1229314-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2346351.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TPSB2NM_024164.6 linkc.376G>C p.Glu126Gln missense_variant Exon 4 of 6 ENST00000606293.5 NP_077078.5 P20231A0A140VJT7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TPSB2ENST00000606293.5 linkc.376G>C p.Glu126Gln missense_variant Exon 4 of 6 1 NM_024164.6 ENSP00000482743.1 P20231

Frequencies

GnomAD3 genomes
AF:
0.00238
AC:
39
AN:
16414
Hom.:
0
Cov.:
3
show subpopulations
Gnomad AFR
AF:
0.0157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00376
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00490
GnomAD2 exomes
AF:
0.00104
AC:
61
AN:
58464
AF XY:
0.000850
show subpopulations
Gnomad AFR exome
AF:
0.0132
Gnomad AMR exome
AF:
0.000588
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000547
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000741
AC:
369
AN:
497862
Hom.:
23
Cov.:
6
AF XY:
0.000632
AC XY:
161
AN XY:
254740
show subpopulations
African (AFR)
AF:
0.0230
AC:
254
AN:
11058
American (AMR)
AF:
0.00192
AC:
34
AN:
17706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12674
East Asian (EAS)
AF:
0.00
AC:
0
AN:
16138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
41370
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22806
Middle Eastern (MID)
AF:
0.00161
AC:
3
AN:
1864
European-Non Finnish (NFE)
AF:
0.0000831
AC:
29
AN:
348930
Other (OTH)
AF:
0.00194
AC:
49
AN:
25316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.582
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00225
AC:
37
AN:
16420
Hom.:
0
Cov.:
3
AF XY:
0.00244
AC XY:
17
AN XY:
6974
show subpopulations
African (AFR)
AF:
0.0145
AC:
29
AN:
1994
American (AMR)
AF:
0.00375
AC:
7
AN:
1866
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
450
East Asian (EAS)
AF:
0.00
AC:
0
AN:
88
South Asian (SAS)
AF:
0.00
AC:
0
AN:
448
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
798
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
76
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
10394
Other (OTH)
AF:
0.00485
AC:
1
AN:
206
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.534
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00438
Hom.:
2
ExAC
AF:
0.0000616
AC:
2

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 27, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
13
DANN
Benign
0.71
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.81
T;T
M_CAP
Uncertain
0.088
D
MetaRNN
Benign
0.019
T;T
MetaSVM
Benign
-0.69
T
PhyloP100
-2.0
PrimateAI
Benign
0.29
T
Sift4G
Benign
0.84
T;T
Vest4
0.19
MutPred
0.55
Loss of disorder (P = 0.1231);.;
MVP
0.29
ClinPred
0.026
T
GERP RS
-1.2
gMVP
0.26
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770859378; hg19: chr16-1279315; API